Gene Symbol | Gene ID | Gene Info |
---|---|---|
Arntl
|
ENSMUSG00000055116.7 | aryl hydrocarbon receptor nuclear translocator-like |
Tfe3
|
ENSMUSG00000000134.11 | transcription factor E3 |
Mlx
|
ENSMUSG00000017801.9 | MAX-like protein X |
Mitf
|
ENSMUSG00000035158.9 | melanogenesis associated transcription factor |
Mlxipl
|
ENSMUSG00000005373.7 | MLX interacting protein-like |
Tfec
|
ENSMUSG00000029553.7 | transcription factor EC |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_113206818_113207027 | Arntl | 543 | 0.806443 | -0.34 | 1.0e-02 | Click! |
chr7_113214863_113215014 | Arntl | 7381 | 0.226415 | -0.26 | 5.1e-02 | Click! |
chr7_113207681_113208262 | Arntl | 414 | 0.869246 | -0.25 | 6.6e-02 | Click! |
chr7_113251091_113251378 | Arntl | 11480 | 0.196804 | 0.24 | 8.1e-02 | Click! |
chr7_113250698_113250986 | Arntl | 11088 | 0.198032 | 0.23 | 8.8e-02 | Click! |
chr6_97929192_97929343 | Mitf | 532 | 0.838054 | 0.49 | 1.6e-04 | Click! |
chr6_97918028_97918368 | Mitf | 11601 | 0.235246 | 0.47 | 2.6e-04 | Click! |
chr6_97807105_97807624 | Mitf | 306 | 0.912738 | -0.45 | 5.7e-04 | Click! |
chr6_97929626_97929824 | Mitf | 74 | 0.981586 | 0.40 | 2.8e-03 | Click! |
chr6_97919501_97919653 | Mitf | 10222 | 0.240240 | 0.35 | 9.2e-03 | Click! |
chr11_101087351_101087947 | Mlx | 345 | 0.721480 | -0.33 | 1.3e-02 | Click! |
chr11_101086864_101087041 | Mlx | 325 | 0.738459 | -0.28 | 4.0e-02 | Click! |
chr11_101086077_101086228 | Mlx | 1125 | 0.254589 | -0.17 | 2.2e-01 | Click! |
chr11_101087155_101087344 | Mlx | 28 | 0.938523 | -0.10 | 4.6e-01 | Click! |
chr11_101090018_101090169 | Mlx | 431 | 0.640952 | 0.06 | 6.8e-01 | Click! |
chr5_135107033_135107333 | Mlxipl | 265 | 0.836013 | -0.40 | 2.6e-03 | Click! |
chr5_135106753_135106950 | Mlxipl | 40 | 0.950734 | -0.32 | 1.6e-02 | Click! |
chr5_135089764_135089935 | Mlxipl | 41 | 0.946574 | -0.06 | 6.4e-01 | Click! |
chr5_135089395_135089546 | Mlxipl | 420 | 0.690624 | -0.05 | 7.2e-01 | Click! |
chr5_135107788_135108074 | Mlxipl | 1013 | 0.353338 | -0.03 | 8.4e-01 | Click! |
chrX_7763770_7764261 | Tfe3 | 26 | 0.940793 | -0.57 | 5.8e-06 | Click! |
chrX_7763577_7763767 | Tfe3 | 271 | 0.795720 | -0.37 | 5.6e-03 | Click! |
chrX_7762013_7763283 | Tfe3 | 10 | 0.941868 | -0.32 | 1.7e-02 | Click! |
chrX_7765793_7766171 | Tfe3 | 1330 | 0.223820 | -0.20 | 1.4e-01 | Click! |
chr6_16855893_16856198 | Tfec | 10049 | 0.255513 | -0.23 | 8.6e-02 | Click! |
chr6_16862170_16862321 | Tfec | 16249 | 0.237933 | -0.21 | 1.2e-01 | Click! |
chr6_16891838_16892249 | Tfec | 6356 | 0.254037 | -0.17 | 2.2e-01 | Click! |
chr6_16855086_16855250 | Tfec | 9172 | 0.258507 | -0.16 | 2.4e-01 | Click! |
chr6_16898406_16898748 | Tfec | 136 | 0.970910 | -0.15 | 2.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_127062800_127064205 | 25.40 |
Cdk4 |
cyclin-dependent kinase 4 |
32 |
0.93 |
chr9_21367360_21368059 | 15.85 |
Ilf3 |
interleukin enhancer binding factor 3 |
162 |
0.89 |
chr18_80286549_80286700 | 15.42 |
Gm37015 |
predicted gene, 37015 |
17056 |
0.11 |
chr11_120114654_120115286 | 14.42 |
Slc38a10 |
solute carrier family 38, member 10 |
4512 |
0.11 |
chr14_14351950_14353283 | 12.55 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr10_62486624_62487492 | 11.85 |
Vps26a |
VPS26 retromer complex component A |
253 |
0.89 |
chr1_85084738_85085997 | 11.31 |
Gm18342 |
predicted gene, 18342 |
5131 |
0.1 |
chr13_12369982_12370308 | 10.64 |
Gm5445 |
predicted gene 5445 |
8013 |
0.16 |
chr4_13157566_13157775 | 10.25 |
Gm11820 |
predicted gene 11820 |
81530 |
0.1 |
chr19_4201097_4202067 | 10.19 |
Rad9a |
RAD9 checkpoint clamp component A |
12 |
0.68 |
chr5_114743003_114743280 | 9.85 |
Git2 |
GIT ArfGAP 2 |
727 |
0.5 |
chr5_74147781_74147946 | 9.83 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
28187 |
0.11 |
chr18_6135442_6136829 | 9.62 |
Arhgap12 |
Rho GTPase activating protein 12 |
37 |
0.98 |
chr7_45466207_45467093 | 8.97 |
Bax |
BCL2-associated X protein |
125 |
0.86 |
chr5_112771440_112771733 | 8.96 |
Myo18b |
myosin XVIIIb |
5655 |
0.21 |
chr7_90129639_90130990 | 8.86 |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
21 |
0.82 |
chr16_87305621_87305981 | 8.76 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
48384 |
0.15 |
chr3_19644048_19644512 | 8.56 |
Trim55 |
tripartite motif-containing 55 |
194 |
0.93 |
chr9_14596490_14596733 | 8.52 |
Amotl1 |
angiomotin-like 1 |
17975 |
0.12 |
chr13_114478386_114478660 | 7.86 |
Fst |
follistatin |
19572 |
0.15 |
chr5_124425503_124426292 | 7.84 |
Sbno1 |
strawberry notch 1 |
17 |
0.62 |
chr7_126582804_126583424 | 7.71 |
Cln3 |
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
0 |
0.93 |
chr11_85139345_85140659 | 7.68 |
Usp32 |
ubiquitin specific peptidase 32 |
34 |
0.97 |
chr17_26939197_26940105 | 7.56 |
Cuta |
cutA divalent cation tolerance homolog |
82 |
0.9 |
chr10_41594987_41595356 | 7.35 |
Ccdc162 |
coiled-coil domain containing 162 |
7418 |
0.15 |
chr14_54988441_54988911 | 7.30 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1258 |
0.2 |
chr12_40379068_40379448 | 7.29 |
Zfp277 |
zinc finger protein 277 |
16374 |
0.22 |
chr11_117780269_117780842 | 7.28 |
Tmc6 |
transmembrane channel-like gene family 6 |
66 |
0.93 |
chr5_115010914_115011989 | 7.06 |
Sppl3 |
signal peptide peptidase 3 |
46 |
0.95 |
chr4_102383217_102383404 | 7.06 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
38208 |
0.22 |
chr14_14354416_14355184 | 6.92 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr1_43247602_43248038 | 6.83 |
Gm29610 |
predicted gene 29610 |
22863 |
0.16 |
chr1_85259970_85261058 | 6.74 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
1556 |
0.27 |
chr9_59062502_59062687 | 6.70 |
Neo1 |
neogenin |
26153 |
0.21 |
chr17_13759899_13761731 | 6.69 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr11_58033741_58033913 | 6.57 |
Larp1 |
La ribonucleoprotein domain family, member 1 |
7786 |
0.15 |
chr4_57670922_57671135 | 6.55 |
Pakap |
paralemmin A kinase anchor protein |
33053 |
0.2 |
chr5_122602364_122602555 | 6.47 |
Ift81 |
intraflagellar transport 81 |
1034 |
0.42 |
chr9_121345573_121345775 | 6.35 |
Gm47092 |
predicted gene, 47092 |
882 |
0.55 |
chr13_44293859_44294037 | 6.33 |
Gm29676 |
predicted gene, 29676 |
13499 |
0.2 |
chr15_102073530_102074727 | 6.32 |
Eif4b |
eukaryotic translation initiation factor 4B |
264 |
0.87 |
chr15_77022532_77022863 | 6.30 |
Mb |
myoglobin |
30 |
0.96 |
chr19_47562071_47562295 | 6.29 |
Slk |
STE20-like kinase |
17495 |
0.13 |
chr18_75130089_75130274 | 6.26 |
Dym |
dymeclin |
4756 |
0.22 |
chr12_72844098_72844553 | 6.23 |
Gm33785 |
predicted gene, 33785 |
26613 |
0.16 |
chr14_69830997_69831190 | 6.16 |
Pebp4 |
phosphatidylethanolamine binding protein 4 |
9327 |
0.17 |
chr8_15062672_15062966 | 6.10 |
Myom2 |
myomesin 2 |
2629 |
0.16 |
chr18_80636989_80637587 | 6.10 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
28313 |
0.15 |
chr12_90946204_90946419 | 6.06 |
Gm47688 |
predicted gene, 47688 |
7929 |
0.18 |
chr15_98149467_98149629 | 6.02 |
Asb8 |
ankyrin repeat and SOCS box-containing 8 |
3842 |
0.14 |
chr8_84846302_84847675 | 6.02 |
Calr |
calreticulin |
54 |
0.67 |
chr4_147963849_147964034 | 5.99 |
Nppb |
natriuretic peptide type B |
21847 |
0.09 |
chr12_91589681_91590731 | 5.95 |
Gtf2a1 |
general transcription factor II A, 1 |
197 |
0.93 |
chr11_5061283_5062641 | 5.93 |
Gas2l1 |
growth arrest-specific 2 like 1 |
2889 |
0.14 |
chr19_45014579_45015973 | 5.90 |
Lzts2 |
leucine zipper, putative tumor suppressor 2 |
76 |
0.94 |
chr11_20311484_20311635 | 5.90 |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
21125 |
0.15 |
chr6_116337548_116338523 | 5.87 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
1 |
0.56 |
chr1_88240493_88241238 | 5.86 |
Mroh2a |
maestro heat-like repeat family member 2A |
2757 |
0.13 |
chr6_54866910_54867061 | 5.86 |
Gm44185 |
predicted gene, 44185 |
35437 |
0.15 |
chr8_120046361_120046577 | 5.85 |
Gm15684 |
predicted gene 15684 |
1182 |
0.39 |
chr11_98509597_98509860 | 5.84 |
Ikzf3 |
IKAROS family zinc finger 3 |
20708 |
0.1 |
chr16_7099840_7100372 | 5.82 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
30260 |
0.27 |
chr13_29627867_29628051 | 5.73 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
110505 |
0.07 |
chr15_99711561_99711712 | 5.69 |
Smarcd1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
3756 |
0.09 |
chr1_39287922_39288115 | 5.69 |
Gm20428 |
predicted gene 20428 |
11453 |
0.17 |
chr4_6415452_6415881 | 5.67 |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
8322 |
0.19 |
chr11_3648511_3649754 | 5.66 |
Morc2a |
microrchidia 2A |
59 |
0.53 |
chr14_101886174_101886385 | 5.62 |
Lmo7 |
LIM domain only 7 |
2160 |
0.42 |
chr3_121509278_121509434 | 5.60 |
Slc44a3 |
solute carrier family 44, member 3 |
17751 |
0.15 |
chr5_113082920_113083078 | 5.59 |
Crybb3 |
crystallin, beta B3 |
1415 |
0.27 |
chr17_46645515_46646560 | 5.58 |
Klc4 |
kinesin light chain 4 |
15 |
0.7 |
chr8_110676672_110677057 | 5.51 |
Vac14 |
Vac14 homolog (S. cerevisiae) |
31284 |
0.14 |
chr4_152246039_152246302 | 5.50 |
Gpr153 |
G protein-coupled receptor 153 |
28062 |
0.1 |
chr19_41980804_41981978 | 5.50 |
Mms19 |
MMS19 cytosolic iron-sulfur assembly component |
234 |
0.62 |
chr4_132608371_132608522 | 5.49 |
Eya3 |
EYA transcriptional coactivator and phosphatase 3 |
30541 |
0.11 |
chr3_37353957_37354220 | 5.48 |
Fgf2os |
fibroblast growth factor 2, opposite strand |
4348 |
0.11 |
chr6_90462168_90464038 | 5.48 |
Klf15 |
Kruppel-like factor 15 |
429 |
0.69 |
chr14_20664048_20664400 | 5.42 |
Synpo2l |
synaptopodin 2-like |
350 |
0.73 |
chr16_94526000_94527258 | 5.40 |
Vps26c |
VPS26 endosomal protein sorting factor C |
188 |
0.94 |
chr2_32317120_32318698 | 5.38 |
Gm23363 |
predicted gene, 23363 |
356 |
0.45 |
chr11_116198327_116199203 | 5.35 |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
36 |
0.55 |
chr3_52603401_52603644 | 5.35 |
Gm10293 |
predicted pseudogene 10293 |
9313 |
0.25 |
chr6_100732315_100732977 | 5.30 |
Gm15576 |
predicted gene 15576 |
6412 |
0.18 |
chr12_95700863_95701014 | 5.29 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
5581 |
0.19 |
chr17_27587307_27587525 | 5.29 |
Nudt3 |
nudix (nucleotide diphosphate linked moiety X)-type motif 3 |
4097 |
0.1 |
chr14_63066988_63067192 | 5.25 |
Defb42 |
defensin beta 42 |
12017 |
0.11 |
chr9_61914174_61915015 | 5.24 |
Rplp1 |
ribosomal protein, large, P1 |
52 |
0.98 |
chr1_156760718_156761135 | 5.22 |
Gm15428 |
predicted pseudogene 15428 |
32586 |
0.12 |
chr19_7240431_7241403 | 5.21 |
Naa40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
117 |
0.93 |
chr2_173736867_173737587 | 5.19 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
284 |
0.88 |
chr11_103378426_103378601 | 5.18 |
Arhgap27 |
Rho GTPase activating protein 27 |
14821 |
0.11 |
chr11_20310810_20310988 | 5.14 |
Rpl12-ps2 |
ribosomal proteimn L12-ps2 |
20516 |
0.15 |
chr11_3142196_3143027 | 5.13 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
233 |
0.74 |
chr9_40478252_40478428 | 5.13 |
Gm5055 |
predicted gene 5055 |
9380 |
0.15 |
chr1_54907146_54907467 | 5.12 |
A130048G24Rik |
RIKEN cDNA A130048G24 gene |
9288 |
0.19 |
chr8_84742133_84743295 | 5.11 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
19707 |
0.09 |
chr15_86104740_86104959 | 5.07 |
Gm15722 |
predicted gene 15722 |
14789 |
0.17 |
chr18_75421496_75421810 | 5.07 |
Smad7 |
SMAD family member 7 |
46739 |
0.14 |
chr13_95610847_95611137 | 5.06 |
F2r |
coagulation factor II (thrombin) receptor |
7495 |
0.17 |
chr2_158122785_158123182 | 5.06 |
Gm20412 |
predicted gene 20412 |
5829 |
0.16 |
chr11_51855495_51856955 | 5.01 |
Jade2 |
jade family PHD finger 2 |
900 |
0.57 |
chr9_123467213_123467380 | 5.00 |
Limd1 |
LIM domains containing 1 |
11410 |
0.17 |
chr5_122647760_122647916 | 4.99 |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
2586 |
0.19 |
chr14_31172687_31173176 | 4.96 |
Nisch |
nischarin |
797 |
0.47 |
chr8_89993734_89993908 | 4.96 |
Gm24212 |
predicted gene, 24212 |
326517 |
0.01 |
chr3_116119158_116119497 | 4.94 |
Vcam1 |
vascular cell adhesion molecule 1 |
1388 |
0.33 |
chr17_62702570_62702721 | 4.91 |
Efna5 |
ephrin A5 |
178499 |
0.03 |
chr4_141420963_141421789 | 4.91 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
597 |
0.56 |
chr14_118907730_118907921 | 4.91 |
Dzip1 |
DAZ interacting protein 1 |
5330 |
0.18 |
chr19_17199209_17199360 | 4.90 |
Prune2 |
prune homolog 2 |
8967 |
0.21 |
chr8_12073375_12073558 | 4.89 |
B020031H02Rik |
RIKEN cDNA B020031H02 gene |
125127 |
0.04 |
chr13_12369051_12369584 | 4.89 |
Gm5445 |
predicted gene 5445 |
8841 |
0.16 |
chr17_12769031_12770256 | 4.89 |
Igf2r |
insulin-like growth factor 2 receptor |
21 |
0.96 |
chr7_132723876_132724242 | 4.88 |
Fam53b |
family with sequence similarity 53, member B |
52857 |
0.11 |
chr10_118799790_118800107 | 4.85 |
Gm4065 |
predicted gene 4065 |
5311 |
0.18 |
chr19_53697480_53697632 | 4.85 |
Rbm20 |
RNA binding motif protein 20 |
20250 |
0.17 |
chr11_74896307_74898160 | 4.83 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr11_116004617_116006105 | 4.81 |
Galk1 |
galactokinase 1 |
7358 |
0.1 |
chr11_70000154_70000936 | 4.79 |
Dvl2 |
dishevelled segment polarity protein 2 |
50 |
0.91 |
chr17_34898151_34899707 | 4.78 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr5_136676435_136676586 | 4.77 |
Myl10 |
myosin, light chain 10, regulatory |
16636 |
0.21 |
chr17_65907188_65907394 | 4.77 |
Gm35550 |
predicted gene, 35550 |
1744 |
0.25 |
chr8_35704896_35705209 | 4.76 |
1700015I17Rik |
RIKEN cDNA 1700015I17 gene |
14897 |
0.15 |
chr9_22002282_22003489 | 4.75 |
Prkcsh |
protein kinase C substrate 80K-H |
79 |
0.71 |
chr1_135156383_135156779 | 4.69 |
Arl8a |
ADP-ribosylation factor-like 8A |
2399 |
0.15 |
chr7_89461391_89461705 | 4.66 |
AI314278 |
expressed sequence AI314278 |
35209 |
0.11 |
chr8_13159108_13159452 | 4.65 |
Lamp1 |
lysosomal-associated membrane protein 1 |
119 |
0.93 |
chr3_84883956_84884121 | 4.65 |
Gm37726 |
predicted gene, 37726 |
10147 |
0.24 |
chr8_46294357_46295046 | 4.64 |
Helt |
helt bHLH transcription factor |
30 |
0.95 |
chr19_45902631_45902822 | 4.64 |
Gm6813 |
predicted gene 6813 |
24600 |
0.14 |
chr9_103601921_103602130 | 4.61 |
Gm38032 |
predicted gene, 38032 |
1861 |
0.32 |
chr9_118694607_118694833 | 4.61 |
Itga9 |
integrin alpha 9 |
8885 |
0.24 |
chr13_94395851_94396175 | 4.61 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
37053 |
0.14 |
chr17_10473990_10474553 | 4.60 |
A230009B12Rik |
RIKEN cDNA A230009B12 gene |
9434 |
0.24 |
chr3_137775065_137775240 | 4.59 |
Mir6380 |
microRNA 6380 |
8463 |
0.15 |
chr3_146197926_146198077 | 4.57 |
Mcoln2 |
mucolipin 2 |
5918 |
0.19 |
chr11_117654482_117655431 | 4.56 |
Tnrc6c |
trinucleotide repeat containing 6C |
143 |
0.96 |
chr9_106886021_106887464 | 4.56 |
Rbm15b |
RNA binding motif protein 15B |
686 |
0.53 |
chr10_83896120_83896314 | 4.55 |
Gm47247 |
predicted gene, 47247 |
5635 |
0.27 |
chr16_92825845_92826239 | 4.54 |
Runx1 |
runt related transcription factor 1 |
32 |
0.98 |
chr7_132900991_132901253 | 4.53 |
Gm45502 |
predicted gene 45502 |
9967 |
0.13 |
chr14_74490678_74490829 | 4.52 |
Gm49174 |
predicted gene, 49174 |
39194 |
0.15 |
chr13_46426958_46427130 | 4.51 |
Rbm24 |
RNA binding motif protein 24 |
5222 |
0.26 |
chr14_74490931_74491126 | 4.50 |
Gm49174 |
predicted gene, 49174 |
39469 |
0.15 |
chr5_142140102_142140271 | 4.48 |
Gm26970 |
predicted gene, 26970 |
142920 |
0.05 |
chr4_43757265_43757477 | 4.48 |
Olfr269-ps1 |
olfactory receptor 269, pseudogene 1 |
10406 |
0.08 |
chr15_85724908_85725104 | 4.48 |
Ppara |
peroxisome proliferator activated receptor alpha |
9977 |
0.13 |
chr5_139338509_139338695 | 4.46 |
Cox19 |
cytochrome c oxidase assembly protein 19 |
973 |
0.42 |
chr8_125401477_125401784 | 4.44 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
91080 |
0.09 |
chr11_120386595_120387016 | 4.43 |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
3302 |
0.11 |
chr19_47902918_47903069 | 4.43 |
Itprip |
inositol 1,4,5-triphosphate receptor interacting protein |
16257 |
0.12 |
chr1_180185977_180186138 | 4.43 |
Coq8a |
coenzyme Q8A |
3257 |
0.19 |
chr13_3898122_3898458 | 4.42 |
Gm47813 |
predicted gene, 47813 |
1958 |
0.22 |
chr9_48707222_48707534 | 4.41 |
Nnmt |
nicotinamide N-methyltransferase |
102225 |
0.06 |
chr10_33732870_33733699 | 4.41 |
Gm47929 |
predicted gene, 47929 |
18392 |
0.17 |
chr1_135835745_135836286 | 4.40 |
Tnnt2 |
troponin T2, cardiac |
339 |
0.83 |
chr4_13364740_13365135 | 4.40 |
Gm11819 |
predicted gene 11819 |
79833 |
0.1 |
chr11_9047203_9047419 | 4.39 |
Gm11992 |
predicted gene 11992 |
1283 |
0.37 |
chr12_86104369_86104717 | 4.38 |
Ift43 |
intraflagellar transport 43 |
12421 |
0.15 |
chr10_84026924_84027102 | 4.38 |
C230099D08Rik |
RIKEN cDNA C230099D08 gene |
22153 |
0.18 |
chr15_62230752_62231120 | 4.38 |
Pvt1 |
Pvt1 oncogene |
8333 |
0.25 |
chr13_37629070_37629705 | 4.37 |
Gm40915 |
predicted gene, 40915 |
1784 |
0.24 |
chr16_26185747_26186199 | 4.35 |
P3h2 |
prolyl 3-hydroxylase 2 |
80189 |
0.11 |
chr9_44079409_44079632 | 4.35 |
Usp2 |
ubiquitin specific peptidase 2 |
5419 |
0.08 |
chr14_120119134_120119337 | 4.35 |
Gm48997 |
predicted gene, 48997 |
11368 |
0.2 |
chr14_63272981_63273156 | 4.32 |
Gata4 |
GATA binding protein 4 |
1376 |
0.41 |
chr17_71268038_71268559 | 4.32 |
Emilin2 |
elastin microfibril interfacer 2 |
299 |
0.88 |
chr13_24477731_24477908 | 4.31 |
Gm22013 |
predicted gene, 22013 |
8945 |
0.17 |
chr1_184171018_184171191 | 4.31 |
Dusp10 |
dual specificity phosphatase 10 |
136723 |
0.04 |
chr9_67191499_67191691 | 4.31 |
Tln2 |
talin 2 |
39812 |
0.13 |
chr6_100975954_100976145 | 4.31 |
Gm43941 |
predicted gene, 43941 |
15060 |
0.19 |
chr9_25076208_25076374 | 4.30 |
Gm10181 |
predicted gene 10181 |
13131 |
0.15 |
chr17_24163033_24163994 | 4.29 |
Amdhd2 |
amidohydrolase domain containing 2 |
151 |
0.89 |
chr7_112656145_112656626 | 4.28 |
Gm45473 |
predicted gene 45473 |
3603 |
0.2 |
chr12_98668509_98668702 | 4.27 |
Spata7 |
spermatogenesis associated 7 |
4960 |
0.14 |
chr7_139469585_139469739 | 4.27 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
11971 |
0.24 |
chr17_15462268_15462438 | 4.26 |
Gm49669 |
predicted gene, 49669 |
2548 |
0.19 |
chr5_36726254_36726643 | 4.25 |
Gm43701 |
predicted gene 43701 |
22170 |
0.11 |
chr12_12274214_12274394 | 4.24 |
Fam49a |
family with sequence similarity 49, member A |
12115 |
0.28 |
chr13_63567343_63568686 | 4.24 |
A930032L01Rik |
RIKEN cDNA A930032L01 gene |
40 |
0.96 |
chr4_139214130_139214337 | 4.23 |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
12728 |
0.15 |
chr10_45181378_45181723 | 4.23 |
Popdc3 |
popeye domain containing 3 |
3452 |
0.25 |
chr9_118693352_118693529 | 4.23 |
Itga9 |
integrin alpha 9 |
7605 |
0.25 |
chr17_10390509_10391133 | 4.22 |
A230009B12Rik |
RIKEN cDNA A230009B12 gene |
65395 |
0.11 |
chr3_107479176_107479476 | 4.20 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
10621 |
0.18 |
chr11_106536171_106536382 | 4.20 |
Tex2 |
testis expressed gene 2 |
30834 |
0.12 |
chr3_87905763_87907208 | 4.19 |
Hdgf |
heparin binding growth factor |
164 |
0.9 |
chr17_26715365_26716214 | 4.18 |
Crebrf |
CREB3 regulatory factor |
65 |
0.97 |
chr4_58631514_58631665 | 4.17 |
Gm12579 |
predicted gene 12579 |
20531 |
0.17 |
chr1_189876286_189876455 | 4.17 |
Gm37422 |
predicted gene, 37422 |
3565 |
0.18 |
chr8_123446138_123446289 | 4.17 |
Def8 |
differentially expressed in FDCP 8 |
726 |
0.38 |
chr8_33978539_33978943 | 4.16 |
Gm39157 |
predicted gene, 39157 |
7173 |
0.16 |
chr15_41869602_41869995 | 4.16 |
Abra |
actin-binding Rho activating protein |
78 |
0.97 |
chr17_86237002_86237170 | 4.15 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
50092 |
0.14 |
chr1_73919880_73920093 | 4.12 |
Tns1 |
tensin 1 |
8231 |
0.21 |
chr14_25629920_25630140 | 4.12 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
22192 |
0.16 |
chr6_145457135_145457443 | 4.11 |
Lmntd1 |
lamin tail domain containing 1 |
6522 |
0.16 |
chr17_66546834_66546985 | 4.09 |
Gm49938 |
predicted gene, 49938 |
14806 |
0.16 |
chr7_135802530_135802829 | 4.09 |
Gm36431 |
predicted gene, 36431 |
33089 |
0.14 |
chr13_69862520_69862693 | 4.06 |
Med10 |
mediator complex subunit 10 |
51021 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 24.3 | GO:0010288 | response to lead ion(GO:0010288) |
3.7 | 11.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.5 | 10.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
3.1 | 9.2 | GO:0036166 | phenotypic switching(GO:0036166) |
3.0 | 12.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.7 | 10.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
2.6 | 13.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
2.4 | 4.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.4 | 7.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
2.4 | 7.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.3 | 6.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.3 | 11.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.2 | 4.5 | GO:0002086 | diaphragm contraction(GO:0002086) |
2.2 | 8.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.1 | 4.1 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
2.1 | 6.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.0 | 6.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
2.0 | 5.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.8 | 5.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.8 | 7.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.7 | 1.7 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.7 | 6.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.7 | 5.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.7 | 5.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.7 | 5.0 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.6 | 9.8 | GO:0015671 | oxygen transport(GO:0015671) |
1.6 | 4.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.6 | 4.8 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.6 | 3.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.6 | 6.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.5 | 4.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.5 | 2.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.4 | 4.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.4 | 5.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.3 | 2.7 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.3 | 4.0 | GO:1902075 | cellular response to salt(GO:1902075) |
1.3 | 13.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.3 | 3.9 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.3 | 3.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 3.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.2 | 6.1 | GO:0015808 | L-alanine transport(GO:0015808) |
1.2 | 4.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.2 | 1.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.2 | 4.7 | GO:0030091 | protein repair(GO:0030091) |
1.2 | 1.2 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.2 | 4.7 | GO:0043622 | cortical microtubule organization(GO:0043622) |
1.2 | 5.8 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.2 | 7.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
1.2 | 2.3 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.2 | 2.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
1.2 | 6.9 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.2 | 1.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.2 | 1.2 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.1 | 1.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.1 | 5.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.1 | 3.3 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.1 | 3.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.1 | 5.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.1 | 3.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.1 | 5.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.1 | 3.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.1 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.1 | 5.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.0 | 4.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.0 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.0 | 1.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
1.0 | 3.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.0 | 3.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.0 | 5.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.0 | 2.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.0 | 8.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.0 | 1.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
1.0 | 11.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.0 | 5.8 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.0 | 2.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 4.8 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
1.0 | 2.9 | GO:0042117 | monocyte activation(GO:0042117) |
1.0 | 7.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.0 | 3.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.9 | 5.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.9 | 2.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.9 | 4.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.9 | 2.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.9 | 5.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.9 | 14.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.9 | 2.8 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.9 | 3.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.9 | 2.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.9 | 0.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 3.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.9 | 0.9 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.9 | 4.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.9 | 2.7 | GO:0032328 | alanine transport(GO:0032328) |
0.9 | 1.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.9 | 2.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.9 | 2.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.9 | 0.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 7.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.9 | 5.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.9 | 1.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.9 | 2.6 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.9 | 4.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.9 | 2.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.9 | 0.9 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.9 | 1.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 1.7 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.8 | 10.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.8 | 4.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 3.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 4.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 0.8 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.8 | 2.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.8 | 1.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.8 | 3.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.8 | 2.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 2.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.8 | 3.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.8 | 6.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.8 | 4.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.8 | 2.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.8 | 3.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.8 | 2.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.8 | 3.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.8 | 2.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.8 | 2.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.8 | 0.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.8 | 2.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.8 | 2.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.8 | 1.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.8 | 3.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.8 | 1.5 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.8 | 1.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.8 | 3.0 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.8 | 2.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.8 | 2.3 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.8 | 0.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.7 | 2.2 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.7 | 6.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.7 | 4.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.7 | 2.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 2.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.7 | 2.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.7 | 2.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.7 | 2.9 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.7 | 3.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.7 | 7.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.7 | 4.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 3.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 2.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.7 | 4.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.7 | 2.8 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.7 | 2.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 2.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 0.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.7 | 2.8 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.7 | 1.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.7 | 2.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 2.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.7 | 5.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.7 | 2.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.7 | 2.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.7 | 1.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.7 | 15.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.7 | 1.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.7 | 3.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.7 | 2.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.7 | 1.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.7 | 2.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.7 | 2.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 2.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 2.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.7 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 1.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.7 | 2.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.7 | 2.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 2.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 2.6 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 2.6 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 5.9 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.7 | 2.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 3.3 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.6 | 1.9 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.6 | 4.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 1.9 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.6 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 5.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 0.6 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.6 | 2.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.6 | 6.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 3.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.6 | 1.3 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.6 | 1.9 | GO:0032898 | neurotrophin production(GO:0032898) |
0.6 | 6.3 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.6 | 2.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 0.6 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.6 | 1.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 5.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.6 | 2.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 1.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.6 | 2.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 1.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.6 | 1.9 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.6 | 1.9 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.6 | 3.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 1.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 1.8 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.6 | 1.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 3.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 1.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.6 | 3.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 3.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 1.8 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.6 | 2.4 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.6 | 2.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.6 | 1.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 2.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.6 | 2.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.6 | 1.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 2.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 3.0 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.6 | 1.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 3.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 4.8 | GO:0097531 | mast cell migration(GO:0097531) |
0.6 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.6 | 0.6 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 1.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.6 | 1.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 2.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 3.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.6 | 1.8 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.6 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 2.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.6 | 2.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 1.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 5.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.6 | 0.6 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.6 | 1.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.6 | 1.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 1.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.6 | 1.7 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.6 | 2.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.6 | 1.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.6 | 2.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.6 | 5.0 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.6 | 1.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 0.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 2.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.5 | 1.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 1.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 2.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 2.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 2.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.5 | 1.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 2.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.5 | 1.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 15.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 1.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.5 | 1.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.5 | 1.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 4.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.5 | 1.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.5 | 2.6 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.5 | 0.5 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.5 | 1.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.5 | 0.5 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
0.5 | 1.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 2.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 1.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.5 | 1.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.5 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 3.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 0.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 1.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.5 | 0.5 | GO:0003284 | septum primum development(GO:0003284) |
0.5 | 6.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 8.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.5 | 6.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.5 | 2.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.5 | 2.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.5 | 1.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.5 | 1.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 2.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.5 | 3.5 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.5 | 4.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.5 | 1.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 8.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.5 | 1.5 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 2.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.5 | 9.0 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.5 | 0.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 1.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 1.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 1.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 3.5 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.5 | 4.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.5 | 1.0 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.5 | 1.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 1.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 1.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.5 | 2.4 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.5 | 1.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 1.9 | GO:0070836 | caveola assembly(GO:0070836) |
0.5 | 3.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.5 | 2.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.5 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.5 | 1.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.5 | 0.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 0.5 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 1.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 6.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.5 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.5 | 1.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 0.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 0.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.5 | 3.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.5 | 1.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 1.4 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.5 | 5.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.5 | 3.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.5 | 3.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 0.5 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.5 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 3.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.5 | 2.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 1.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 1.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 1.4 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.5 | 4.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 3.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 3.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 2.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 2.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 0.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.5 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 0.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.5 | 1.4 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.5 | 1.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 0.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.5 | 0.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 0.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 1.8 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.4 | 1.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 0.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 0.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 3.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 2.2 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.4 | 2.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 3.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.4 | 0.9 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.4 | 0.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 0.4 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.4 | 0.4 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.4 | 3.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.4 | 1.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 0.9 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 1.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.4 | 2.5 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 2.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 2.9 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.4 | 2.5 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.4 | 0.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 1.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 0.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 1.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 1.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 0.4 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.4 | 2.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 1.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.4 | 1.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 1.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 0.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.4 | 0.8 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 1.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 0.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 1.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.4 | 0.8 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 0.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 0.8 | GO:0051029 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.4 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 4.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 2.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 2.4 | GO:0051255 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.4 | 2.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 0.4 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.4 | 1.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 4.7 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 0.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 1.6 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.4 | 0.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 0.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.4 | 1.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.4 | 2.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.4 | 2.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 1.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 0.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.4 | 1.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 0.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.4 | 1.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.4 | 7.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.4 | 1.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.4 | 0.8 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 0.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 1.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 2.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 2.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 1.9 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.4 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 4.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 1.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.4 | 3.8 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.4 | 0.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.4 | 0.7 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 1.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 3.4 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 1.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.4 | 1.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 1.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.4 | 0.7 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.4 | 1.1 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 0.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 0.7 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.4 | 3.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 1.8 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 0.7 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 2.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.4 | 2.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.4 | 0.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 3.2 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.4 | 4.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 1.4 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.4 | 2.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 2.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 0.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 2.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.4 | 1.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 3.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.4 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 1.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.3 | 2.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 2.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.7 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 1.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.7 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.3 | 1.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 1.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 1.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 1.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.3 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 0.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.3 | 3.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 2.7 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 1.4 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.3 | 2.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 1.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 1.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.3 | 1.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 1.0 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 1.3 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.3 | 0.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 2.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 0.3 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 2.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 4.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 1.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.3 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.3 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 2.9 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.3 | 2.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 1.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 0.7 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 1.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 0.3 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.3 | 1.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 1.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 1.6 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 2.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 2.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 1.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 0.6 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.3 | 1.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 0.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.3 | GO:0036394 | amylase secretion(GO:0036394) |
0.3 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.3 | 0.3 | GO:0070293 | renal absorption(GO:0070293) |
0.3 | 0.6 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.3 | 2.5 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.3 | 2.5 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 2.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 3.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 1.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 1.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 5.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.3 | 0.9 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.3 | 0.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 0.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 0.9 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.3 | 2.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 8.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.3 | 0.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 0.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.3 | 0.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.9 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.3 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.6 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.6 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 4.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 0.3 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.3 | 0.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 2.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 1.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 0.9 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.3 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.9 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.3 | 3.2 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 4.4 | GO:0048747 | muscle fiber development(GO:0048747) |
0.3 | 2.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 0.3 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.3 | 1.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.3 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 1.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 1.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.4 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.3 | 2.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 2.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 0.6 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 3.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 1.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 1.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.3 | 2.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 1.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.3 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.3 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 1.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 0.6 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 5.0 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 1.1 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.3 | 0.6 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.3 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.3 | 1.9 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.3 | 1.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.3 | 1.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 4.3 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.3 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 0.5 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.3 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 0.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.3 | 14.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 0.8 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.3 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 5.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.3 | 1.0 | GO:0015669 | gas transport(GO:0015669) |
0.3 | 1.0 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.3 | 0.3 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.3 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 1.3 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 0.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.3 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.3 | 0.5 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.3 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 1.5 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.3 | 0.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 3.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 0.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 0.8 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 2.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 1.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 1.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 1.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.3 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 7.6 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 2.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 2.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 0.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 1.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 1.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 0.2 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
0.2 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.2 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 0.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.2 | 2.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.2 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.2 | 3.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 3.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 2.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 1.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 2.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 4.0 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 4.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 0.2 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.2 | 12.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 2.1 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.9 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 1.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 2.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 1.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 1.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 2.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 1.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 3.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 1.6 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 1.8 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.7 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 0.2 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.7 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 1.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 1.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 1.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.5 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 2.4 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.2 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 0.2 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 1.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.9 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 1.3 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 1.3 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.2 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.4 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.4 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.2 | 0.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 1.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 4.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 2.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.2 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 1.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 2.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 1.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.4 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.4 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.8 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 1.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 1.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 2.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.6 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.2 | 0.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.4 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 1.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 1.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 2.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 1.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 1.0 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.2 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 1.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 1.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 3.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0010224 | response to UV-B(GO:0010224) |
0.2 | 3.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.4 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 2.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.6 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 5.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 1.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.2 | 0.2 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.2 | 0.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 1.9 | GO:0051187 | coenzyme catabolic process(GO:0009109) cofactor catabolic process(GO:0051187) |
0.2 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 1.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.2 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.2 | 0.2 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.2 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.4 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 1.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 0.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 1.5 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.4 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.2 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 1.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 2.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 3.5 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 0.5 | GO:0006848 | pyruvate transport(GO:0006848) |
0.2 | 0.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.3 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 3.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 1.9 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 2.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 1.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 4.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 2.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.2 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.5 | GO:0044038 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.7 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.2 | 9.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 0.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.2 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.2 | 1.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.7 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 1.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 1.0 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.2 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.9 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
0.2 | 0.5 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 2.7 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.2 | 0.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 0.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 1.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 2.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.2 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.2 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 1.7 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.2 | 2.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.6 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 1.8 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.7 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.4 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 2.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 1.1 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.1 | 2.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 2.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.1 | 0.4 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 1.0 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 1.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.9 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.7 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.1 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.9 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.4 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.1 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 3.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 1.8 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.2 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 3.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.6 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 2.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 1.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 1.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 2.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 2.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.7 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.5 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 1.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.6 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 1.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.1 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 1.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.1 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.4 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 1.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.5 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 0.7 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 1.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.5 | GO:2000269 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.2 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 4.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 1.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 2.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.4 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.6 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.6 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.2 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.3 | GO:0042363 | vitamin catabolic process(GO:0009111) diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.4 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 1.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.1 | 1.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.2 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.2 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 3.1 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.1 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.1 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.6 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:0014856 | skeletal muscle cell proliferation(GO:0014856) |
0.1 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.4 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.1 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.6 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.1 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 1.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.1 | GO:0032608 | interferon-beta production(GO:0032608) |
0.1 | 0.3 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 1.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 5.4 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.2 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 2.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.1 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.1 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.8 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 3.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 2.6 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.4 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.1 | GO:1902590 | multi-organism membrane organization(GO:0044803) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.1 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.1 | 0.2 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 1.2 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.4 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.2 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.0 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 1.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.0 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 1.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.0 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.0 | 0.2 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 1.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.0 | 0.1 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 | 0.0 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.0 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.0 | 0.2 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 3.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.0 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 2.0 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) regulation of circadian sleep/wake cycle(GO:0042749) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.3 | 21.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.2 | 17.8 | GO:0005861 | troponin complex(GO:0005861) |
2.2 | 11.1 | GO:0097422 | tubular endosome(GO:0097422) |
2.2 | 6.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.2 | 8.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.9 | 5.6 | GO:0032010 | phagolysosome(GO:0032010) |
1.8 | 1.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.7 | 5.1 | GO:0097413 | Lewy body(GO:0097413) |
1.7 | 8.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.6 | 1.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.5 | 7.4 | GO:0005638 | lamin filament(GO:0005638) |
1.5 | 4.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 7.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
1.4 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.2 | 7.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.2 | 3.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.2 | 4.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 5.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.1 | 3.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.1 | 1.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.0 | 4.2 | GO:0097452 | GAIT complex(GO:0097452) |
1.0 | 10.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 2.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.0 | 4.1 | GO:0000322 | storage vacuole(GO:0000322) |
1.0 | 2.0 | GO:0031523 | Myb complex(GO:0031523) |
1.0 | 5.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.0 | 3.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 13.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.0 | 3.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.9 | 12.9 | GO:0031430 | M band(GO:0031430) |
0.9 | 2.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 1.8 | GO:0016342 | catenin complex(GO:0016342) |
0.9 | 9.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.9 | 4.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 2.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.8 | 4.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.8 | 5.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 2.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.8 | 1.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 4.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.8 | 5.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.7 | 2.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 22.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 68.6 | GO:0031674 | I band(GO:0031674) |
0.7 | 0.7 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.7 | 8.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.7 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.7 | 2.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.7 | 3.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 4.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 6.1 | GO:0043034 | costamere(GO:0043034) |
0.7 | 11.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.7 | 7.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 21.4 | GO:0030016 | myofibril(GO:0030016) |
0.6 | 1.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.6 | 1.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 3.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 3.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 4.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.6 | 3.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 1.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 1.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 8.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.6 | 1.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 0.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 5.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 1.6 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 5.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.5 | 2.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 1.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 3.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 1.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 1.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 1.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 0.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.5 | 1.4 | GO:0089701 | U2AF(GO:0089701) |
0.5 | 1.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 1.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 3.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 0.4 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.4 | 3.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 1.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 0.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 3.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 4.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 2.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 2.9 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.4 | 1.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 1.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 16.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 1.6 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 2.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 5.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 4.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 1.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 2.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 1.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 6.1 | GO:0002102 | podosome(GO:0002102) |
0.4 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 29.1 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 2.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 3.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.4 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 7.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 3.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.8 | GO:0016528 | sarcoplasm(GO:0016528) |
0.4 | 30.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 1.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 3.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 1.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 1.4 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.4 | 1.1 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 1.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 2.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 2.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 2.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.7 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 1.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 1.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 12.6 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 3.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 3.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 2.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 2.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 5.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 6.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 0.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 77.5 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.3 | 16.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 2.8 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.9 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 1.6 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 10.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 5.8 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 1.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.3 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 6.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 1.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 2.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 0.9 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 1.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 2.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 0.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.7 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.3 | 1.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 2.2 | GO:0071010 | prespliceosome(GO:0071010) |
0.3 | 0.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 3.0 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 19.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.3 | 1.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 0.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 3.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 4.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 11.4 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.7 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 3.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.9 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 2.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 1.8 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 5.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.6 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 1.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 2.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 5.9 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 3.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.1 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 3.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 4.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 1.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 1.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.2 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 4.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 3.1 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 1.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 3.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 8.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 5.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 2.1 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 2.1 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 3.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 0.7 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 1.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 1.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.0 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 6.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 1.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 6.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 0.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.2 | 1.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 8.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 1.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 8.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 2.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 1.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 2.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.0 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 6.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 16.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 25.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 4.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 2.3 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 5.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 4.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 4.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 2.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 2.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 5.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 4.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 2.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 10.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.3 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 1.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 2.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 6.2 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.6 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 2.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 1.9 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 1.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 3.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 6.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 2.6 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 24.2 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 8.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 2.7 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 2.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.3 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 3.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 3.4 | GO:0005819 | spindle(GO:0005819) |
0.0 | 1.2 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.0 | 0.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 6.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 19.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.9 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 1.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 1.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 3.6 | GO:0005740 | mitochondrial envelope(GO:0005740) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.2 | GO:0030172 | troponin C binding(GO:0030172) |
2.5 | 7.6 | GO:0051373 | FATZ binding(GO:0051373) |
2.4 | 9.4 | GO:0031433 | telethonin binding(GO:0031433) |
2.2 | 8.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.1 | 15.0 | GO:0031432 | titin binding(GO:0031432) |
1.8 | 7.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.7 | 8.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.7 | 6.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.6 | 6.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.6 | 4.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.6 | 9.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.6 | 4.8 | GO:0055100 | adiponectin binding(GO:0055100) |
1.5 | 4.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.4 | 8.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.4 | 5.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.3 | 3.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.2 | 4.9 | GO:0030911 | TPR domain binding(GO:0030911) |
1.2 | 3.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.2 | 8.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 3.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.2 | 2.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.2 | 3.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.1 | 1.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
1.1 | 9.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.1 | 4.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.1 | 12.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.1 | 3.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 1.1 | GO:0031013 | troponin I binding(GO:0031013) |
1.1 | 9.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.1 | 3.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.1 | 3.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.0 | 3.1 | GO:0050692 | DBD domain binding(GO:0050692) |
1.0 | 3.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.0 | 3.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.0 | 12.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.0 | 3.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.0 | 21.7 | GO:0030332 | cyclin binding(GO:0030332) |
1.0 | 6.8 | GO:0043719 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.0 | 3.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.0 | 2.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 | 3.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.9 | 2.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.9 | 9.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 2.7 | GO:0070538 | oleic acid binding(GO:0070538) |
0.9 | 6.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.9 | 6.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 5.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.9 | 10.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 2.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.9 | 3.5 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 3.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.9 | 7.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.9 | 6.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 0.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.8 | 4.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 3.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.8 | 8.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.8 | 7.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.8 | 3.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 2.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.8 | 4.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.8 | 6.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.8 | 3.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 5.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.8 | 2.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 3.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.8 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 3.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.8 | 3.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.7 | 2.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 9.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 0.7 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.7 | 15.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 0.7 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.7 | 2.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 2.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 2.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 2.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.7 | 0.7 | GO:0048185 | activin binding(GO:0048185) |
0.7 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 3.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 2.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 2.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.7 | 4.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 12.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.7 | 2.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 1.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 1.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 2.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 2.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 1.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.6 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 3.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.6 | 3.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 1.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 4.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 1.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 1.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 2.4 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 3.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.6 | 2.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.6 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 1.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 3.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.6 | 2.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.6 | 4.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.6 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 11.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 2.9 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 3.4 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 2.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 0.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 1.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 2.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 1.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.6 | 2.8 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.6 | 2.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 1.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.6 | 3.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.5 | 4.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.5 | 5.9 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 2.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 2.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 5.8 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.5 | 1.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 1.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 2.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 3.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 9.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 1.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 3.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 2.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 1.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.5 | 2.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 2.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 4.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 1.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 2.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 1.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 4.0 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 4.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 2.5 | GO:0046332 | SMAD binding(GO:0046332) |
0.5 | 2.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 2.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 2.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 1.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 2.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 13.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 0.5 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.5 | 1.9 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.5 | 1.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 1.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 6.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 4.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.5 | 1.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 1.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 4.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.5 | 7.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 1.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.8 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.4 | 3.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 0.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 1.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 5.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 3.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 1.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 1.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 1.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.4 | 3.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 1.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 0.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 10.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 8.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 2.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 3.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 2.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 1.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 4.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 7.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 2.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.4 | 4.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 2.0 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 3.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.4 | 3.7 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 21.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 2.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 2.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 2.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 1.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 2.4 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.4 | 2.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 3.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.4 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 1.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 0.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 0.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 0.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.4 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 0.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 1.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 18.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 1.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 1.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 2.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 1.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 4.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 5.0 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 2.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 5.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 19.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 2.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.7 | GO:0051379 | epinephrine binding(GO:0051379) |
0.3 | 1.7 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 0.3 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.3 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 1.0 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 2.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 8.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 3.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 1.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 11.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.3 | 0.3 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.3 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 1.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 2.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 0.6 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.3 | 8.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 5.4 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 0.9 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 2.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 4.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 2.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 2.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.9 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 2.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 6.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 1.8 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 0.9 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 4.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 3.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 2.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 10.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 3.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 3.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 3.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 2.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 7.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 2.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 18.6 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 0.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 6.9 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 0.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 2.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 3.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 0.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 0.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 1.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 7.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.3 | 0.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 1.0 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 3.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 7.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 2.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 2.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 2.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 7.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 1.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.5 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 6.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 2.0 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.2 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 2.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 2.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.2 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.2 | 0.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 6.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 9.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 1.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.8 | GO:0097617 | annealing activity(GO:0097617) |
0.2 | 48.5 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 1.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.2 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 4.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 1.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 4.0 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 7.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 1.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 3.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.1 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.4 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 3.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 2.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 2.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.9 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 2.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 1.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 8.2 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 5.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 4.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 4.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.5 | GO:0018557 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 4.0 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 14.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 3.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 8.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 5.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 3.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 10.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 1.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 2.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 5.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 3.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 3.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 2.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 4.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.5 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 8.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 2.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 7.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 3.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 4.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 21.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 11.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.0 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 1.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 3.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 12.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 2.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 11.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 2.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 4.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 4.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 6.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.5 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.1 | 2.9 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 2.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.2 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 6.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 5.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 1.3 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 2.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 3.6 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 1.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 11.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 2.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 2.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 4.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0008758 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.5 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 1.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 3.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 1.3 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.7 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 6.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 1.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 6.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 1.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 4.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 3.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 3.5 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 1.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 24.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.3 | 2.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.0 | 2.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 0.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 16.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.7 | 10.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 28.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 5.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 8.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 3.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 21.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 4.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 9.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 13.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 14.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 5.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 2.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 10.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 5.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 13.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 3.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 4.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 6.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 7.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 10.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 3.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 15.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 2.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 3.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 6.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 1.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 3.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 13.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 5.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 8.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 2.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 14.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 7.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 6.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 15.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 14.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 4.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 22.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 4.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 7.9 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 3.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 1.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 7.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 4.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 5.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 3.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 2.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 2.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 2.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 3.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 4.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 0.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 2.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 2.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 11.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 4.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 3.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 1.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 2.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 34.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 3.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 3.8 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.1 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 3.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 20.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 4.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 6.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 14.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 47.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.2 | 6.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.2 | 1.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.1 | 30.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.1 | 9.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.9 | 10.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.8 | 19.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.8 | 15.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 7.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 7.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.7 | 5.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.7 | 5.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.7 | 7.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 2.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.6 | 6.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 13.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 6.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 7.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 9.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 12.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 6.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 1.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 4.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 0.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.5 | 3.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 5.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 5.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 12.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 3.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 0.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.5 | 4.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 6.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 9.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 3.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 4.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 15.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 3.2 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 4.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 6.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 2.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 10.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 8.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.4 | 3.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 2.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 23.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 1.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 8.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 12.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 2.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 3.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 1.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 5.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 3.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 1.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 1.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 5.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 2.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 2.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 5.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 5.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.3 | 1.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 2.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 27.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 2.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 1.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 3.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 19.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 15.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 5.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 10.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 5.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 3.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 4.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 1.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 9.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 1.6 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 1.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 15.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.2 | 1.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 21.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 2.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 3.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 6.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 1.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 1.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 4.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 0.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 8.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 1.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 0.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 8.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 3.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 7.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 0.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.2 | 16.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 1.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 1.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 4.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.2 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 2.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 4.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 3.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.4 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 1.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 3.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 6.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 14.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 9.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.6 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.2 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 0.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 3.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.0 | 3.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 3.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.3 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |